Allogene Therapeutics Inc
NASDAQ:ALLO

Watchlist Manager
Allogene Therapeutics Inc Logo
Allogene Therapeutics Inc
NASDAQ:ALLO
Watchlist
Price: 2.54 USD -6.62% Market Closed
Market Cap: 531.1m USD
Have any thoughts about
Allogene Therapeutics Inc?
Write Note

Allogene Therapeutics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Allogene Therapeutics Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Allogene Therapeutics Inc
NASDAQ:ALLO
Cash from Investing Activities
$88.2m
CAGR 3-Years
-17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$19.7B
CAGR 3-Years
-121%
CAGR 5-Years
N/A
CAGR 10-Years
-20%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$4B
CAGR 3-Years
31%
CAGR 5-Years
6%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$27.7B
CAGR 3-Years
-304%
CAGR 5-Years
N/A
CAGR 10-Years
-5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.6B
CAGR 3-Years
N/A
CAGR 5-Years
-57%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$2.9B
CAGR 3-Years
8%
CAGR 5-Years
-7%
CAGR 10-Years
-17%

See Also

What is Allogene Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
88.2m USD

Based on the financial report for Sep 30, 2024, Allogene Therapeutics Inc's Cash from Investing Activities amounts to 88.2m USD.

What is Allogene Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-17%

Over the last year, the Cash from Investing Activities growth was -39%. The average annual Cash from Investing Activities growth rates for Allogene Therapeutics Inc have been -17% over the past three years .

Back to Top